E2	Drug:T2 
E3	And:T3 Arg2:E1 Arg:E22
E4	Drug:T4 Name:T22
E6	Negation:T6 Negates:E7 Negates2:E9
E7	Condition:T7 Name:T23
E8	Or:T8 Arg:E7 Arg2:E9
E9	Condition:T9 Name:T24
E10	Condition:T10 Name:T25
E11	Condition:T11 Name:T26
E12	Or:T12 Arg:E11 Arg2:E14
E13	Eq-Comparison:T13 Temporal-Period:T27
E14	Drug:T14 Temporality:E13
E15	Drug:T15 Name:T28
E16	Or:T16 Arg:E15 Arg2:E18
E17	Other:T17 Is-Other:E18
E18	Drug:T18 Name:T29
E19	Temporal-Connection:T19 Arg:E18 Arg2:E20
E20	Study:T20 
E21	Negation:T21 Negates:E20
E22	Negation:T30 Negates:E2
E1	Negation:T1 Negates:E4
E5	And:T5 Arg:E9 Arg2:E10
T2	Drug 114 124	medication
T3	And 125 128	and
T4	Drug 143 162	dietary supplements
T6	Negation 191 193	no
T7	Condition 194 218	blood clotting disorders
T8	Or 219 221	or
T9	Condition 222 235	dyslipidaemia
T10	Condition 274 292	clotting disorders
T11	Condition 294 306	dyslipidemia
T12	Or 307 309	or
T13	Eq-Comparison 316 318	on
T14	Drug 319 329	medication
T15	Drug 336 343	statins
T16	Or 345 347	or
T17	Other 348 353	other
T18	Drug 354 365	supplements
T19	Temporal-Connection 366 372	during
T20	Study 377 382	study
T21	Negation 391 399	excluded
T22	Drug-Name 143 162	dietary supplements
T23	Condition-Name 194 218	blood clotting disorders
T24	Condition-Name 222 235	dyslipidaemia
T25	Condition-Name 274 292	clotting disorders
T26	Condition-Name 294 306	dyslipidemia
T27	Eq-Temporal-Period 316 318	on
T28	Drug-Name 336 343	statins
T29	Drug-Name 354 365	supplements
T30	Negation 110 113	off
T1	Negation 129 132	off
T5	And 236 239	and
A3	Temporal-Connection-Type-Value E19 during
A4	Eq-Temporal-Period-Value T27 present
R1	Example-Of Arg1:E15 Arg2:E14
